Skip to main content
SNWV logo

SNWV · SANUWAVE Health, Inc.

$6.50 +0.14 (+2.20%) At close · Jul 29
Market Cap
$54.69M
Shares
8.60M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$6.36 Open$6.10 Day$6.00–6.55 52W$5.77–46.59 Avg vol 30d316K Short int615K · 7.2% float · 1.9d Short vol43% Last earningsMar 26, 2026 DataOct 2024–Jul 2026 Filing10-Q · May 12

Up next

Next earnings call
Aug 9, 2026 Est · unconfirmed · in 1 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed May 12, 2026

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Neutral Fundamentals Excellent Quant / Vol Very High
Market backdrop VIX 20.7 · elevated Equity put/call 0.61
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −72%
below
Price vs 50-day avg −46%
below
RSI (14) 34
neutral
MACD trend Negative
52-week position 1%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −26%
trailing
6-month return −76%
trailing
YTD return −79%
this year
Relative strength −84%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $12 › 200d $22 — 200d above 50d
Institutional flow Distributing
13 of 62 funds reported for Jun 30 · net -12.6K sh shares · +1 new
Insider flow Distributing
Net -$170.5K over 90 days · 100% sells
Short interest Falling
7.15% of float · ▼ -2.5% MoM · 1.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
62 holders — near 1-yr high, broad support
Squeeze score 59
elevated · 0–100
Fundamentals
Excellent
Revenue growth +35%
Y/Y
Gross margin 77%
expanding
EPS growth +106%
Y/Y
Free cash flow $1.9M
Valuation P/E 6.6
below peers
Balance sheet $9.9M
net debt
Quant / Vol
risk profile
Very High
Volatility 95%
annualized · 1-yr
Max drawdown −87%
past year
ATR 16.7%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the 8-K filed May 12, 2026
Revenue growth · Q2 2026 Initiated 10% – 15%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−72% Bearish
Price vs 50-day avg
−46% Bearish
RSI (14)
34 Neutral
MACD trend
Negative Bearish
52-week position
1% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $12 › 200d $22 — 200d above 50d
Institutional flow Distributing
13 of 62 funds reported for Jun 30 · net -12.6K sh shares · +1 new
Insider flow Distributing
Net -$170.5K over 90 days · 100% sells
Short interest Falling
7.15% of float · ▼ -2.5% MoM · 1.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
62 holders — near 1-yr high, broad support
Price context
position in its 52-week range
52-wk low $6 Now $6 · 1% 52-wk high $47
vs 200-day avg -72% vs 50-day avg -46%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from its earnings releases, calls, and filings
Metric Latest Period YoY
Gross margin 77.3% Q1 2026

Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

Versus peers

Medical Devices — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
SNWV
SANUWAVE Health, Inc.
this stock
$54.69M -78.7% +35.0% 6.6 7.2%
ABT
Abbott Laboratories
$186.84B -13.9% +5.7% 30.1 1.4%
SYK
Stryker Corp
$132.87B -1.1% +11.2% 40.1 1.8%
MDT
Medtronic plc
$111.21B -8.8% +8.4% 23.3 1.5%
BSX
Boston Scientific Corp
$68.43B -51.7% +5.5% 19.3 1.9%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
56
% held
47.7%
Reported
13 of 62
Top holder
Opaleye Management Inc.
Held Float
View
Held by Funds
Fund positions
83
View
Short & Settlement
Short Interest Falling
Shares short
615.0K
Days to cover
1.9d
Change
-15.5K sh
View
Short Volume
Short vol %
43%
As of
Jul 29, 2026
Short Total
View
Fails to Deliver
FTD shares
38.1K
Value
$375.3K
As of
Jun 30, 2026
View
Off-Exchange
Off-exchange %
44.1%
Week of
May 4, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$170.5K
Buyers / Sellers
0 / 1
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$44.1M
Net income (FY)
$11.8M
EPS diluted
$0.41
View
Filings
SEC Filings
Latest
8-K
Filed
Jul 13, 2026
This year
11
View
Proposed Sales
Value
$5.1M
Shares
155.4K
Filed
Jun 25, 2025
View
Exempt Offerings
Offering
$1.8M
Filed
Jul 2, 2024
View
Earnings & Events
Earnings Calls
Last call
Mar 26, 2026
View

Performance

5D 20D 120D MTD YTD
SNWV -0.6% -26.1% -76.1% -36.4% -78.7%
SPY -1.0% 0.0% +7.4% -0.8% +8.6%
vs SPY +0.4% -26.1% -83.6% -35.6% -87.3%
Key facts CIK 1417663 CUSIP 80303D305 13F (30d) 6 filings 6 filers Visit website Investor relations